临床实践是否需要对所有样本用LC-MS/MS定量25OHD2和25OHD3?
本研究基于北京协和医院2015年5月至2017年1月23,695例维生素D检测数据,用LC-MS/MS分别测定25OHD2和25OHD3。结果显示16.4%的患者可检出25OHD2,男性检出率显著低于女性,且25OHD2与25OHD3呈显著负相关。提示中国患者中25OHD2检出率较高,临床选择检测方法时需考虑。
要点
- 23,695例中16.4%可检出25OHD2(≥2.5 ng/mL)。
- 男性25OHD2检出率13.9%显著低于女性17.5%。
- 25OHD2与25OHD3呈负相关(r=-0.197,p<0.01)。
核心结论
- 中国维生素D检测人群中25OHD2检出率相对较高,且25OHD2与25OHD3显著负相关。
研究设计与样本
- 回顾性分析北京协和医院2015年5月至2017年1月23,695例维生素D检测患者数据,采用LC-MS/MS分别定量25OHD2和25OHD3。
主要发现
- 25OHD2(≥2.5 ng/mL)在16.4%(3877/23,695)的患者中可检出。
- 男性检出率13.9%(1077例),中位数3.7 ng/mL(2.5%-97.5%:2.5-17.2 ng/mL)。
- 女性检出率17.5%(2800例),中位数4.0 ng/mL(范围:2.5-20.6 ng/mL)。
- 在3877例可检出25OHD2的患者中,男性25OHD3水平显著更高(p<0.01),但总25OHD无显著差异。
- 25OHD2占总25OHD的比例为1.3%-100%,87.5%(3391/3877)的样本25OHD2<10 ng/mL。
临床怎么用
- 临床实验室在选择维生素D检测方法时,需考虑患者群体中25OHD2的检出情况,以免漏检。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The demand for vitamin D testing is increasing in China. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) immunoassay is specific and accurate but requires expensive equipment, experienced operators, and complicated pretreatment of serum. Automated immunoassays are simple and convenient but only determine total 25-hydroxyvitamin D (25OHD). The objective of this study was to quantify 25OHD2 and 25OHD3 in patients to assist clinical physicians and laboratory directors in choosing the most appropriate method to determine 25OHD. METHODS: Vitamin D testing was conducted for 23,695 patients in Peking Union Medical College Hospital from May 2015 to January 2017. Using this large data set, the prevalence and levels of 25OHD2 were analyzed. LC-MS/MS was used to separately determine 25OHD2 and 25OHD3. RESULTS: 25OHD2 (≥2.5 ng/mL) was detected in 16.4% (3877/23,695) of patients. Males had a significantly lower incidence of detectable 25OHD2 (p<0.01); 1077 (13.9%) samples contained detectable 25OHD2 (median: 3.7 ng/mL; 2.5%-97.5%: 2.5-17.2 ng/mL). For females, 2800 (17.5%) samples contained detectable 25OHD2 (median: 4.0 ng/mL; range: 2.5-20.6 ng/mL). Of the 3877 patients with detectable 25OHD2, males had a significantly higher level of 25OHD3 (p<0.01). There was no significant difference in total 25OHD. The proportion of 25OHD2 in total 25OHD was 1.3%-100%; 87.5% (3391/3877) of the samples contained <10 ng/mL 25OHD2. 25OHD2 negatively correlated with 25OHD3 (r=-0.197, p<0.01) and positively correlated with total 25OHD (r=0.217, p<0.01). CONCLUSIONS: Prevalence of 25OHD2 in patients tested for vitamin D is relatively high in China. 25OHD2 is significantly negatively correlated with 25OHD3.
引用
- Yu S, Zhang R, Zhou W, et al. Is it necessary for all samples to quantify 25OHD2 and 25OHD3 using LC-MS/MS in clinical practice? Clin Chem Lab Med. 2018. PMID: 28822224. doi:10.1515/cclm-2017-0520
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。